Abstract:In recent years, immunotherapy has developed rapidly as a new field of tumour therapy. However, the efficacy of tumour immunotherapy is not satisfactory due to the immune evasion mechanism of tumour cells, induction of immunosuppressive tumour microenvironment (TME), and reduction of antigen delivery, etc. CRISPR/Cas9 gene editing technology can accurately modify immune and tumour cells in tumours, and improve the efficacy of immunotherapy by targeting immune checkpoint molecules and immune regulatory genes, which has led to the great development and application. In current clinical trials, there are still many obstacles to the application of CRISPR/Cas9 in tumour immunotherapy, such as ensuring the accuracy and safety of gene editing, overcoming overreactive immune responses, and solving the challenges of in vivo drug delivery. Here we provide a systematic review on the application of CRISPR/Cas9 in tumour therapy to address the above existing problems. We focus on CRISPR/Cas9 screening and identification of immunomodulatory genes, targeting of immune checkpoint molecules, manipulation of immunomodulators, enhancement of tumour-specific antigen presentation and modulation of immune cell function. Second, we also highlight preclinical studies of CRISPR/Cas9 in animal models and various delivery systems, and evaluate the efficacy and safety of CRISPR/Cas9 technology in tumour immunotherapy. Finally, potential synergistic approaches for combining CRISPR/Cas9 knockdown with other immunotherapies are presented. This study underscores the transformative potential of CRISPR/Cas9 to reshape the landscape of tumour immunotherapy and provide insights into novel therapeutic strategies for cancer patients.

The CRISPR-Cas9 System: a Promising Tool for Discovering Potential Approaches to Overcome Drug Resistance in Cancer

CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer

CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy

Developing Pioneering Pharmacological Strategies with CRISPR/Cas9 Library Screening to Overcome Cancer Drug Resistance

CRISPR/Cas9 and its application in drugs development

Application of CRISPR-Cas 9 system in cancer therapy

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy

Exposing Cancer with CRISPR-Cas9: from Genetic Identification to Clinical Therapy

CRISPR–Cas: a tool for cancer research and therapeutics

CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment

Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

CRISPR/Cas9: a powerful tool in colorectal cancer research

Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy

The role of the CRISPR‐Cas system in cancer drug development: Mechanisms of action and therapy

CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications

Cancer Research Using Crispr/Cas9 Gene Editing Technology

CRISPR Applications in Cancer Diagnosis and Treatment

Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review